In the BioHarmony Drug Report Database

"Preview" Icon

Nystatin

Candex, Mycostatin, Nilstat, Nysert (nystatin) is a small molecule pharmaceutical. Nystatin was first approved as Candex on 1982-01-01. It is used to treat chronic mucocutaneous candidiasis, cutaneous candidiasis, mycoses, oral candidiasis, and vulvovaginal candidiasis in the USA.

 

Trade Name

 

Candex, Mycostatin, Nilstat, Nysert
 

Common Name

 

nystatin
 

ChEMBL ID

 

CHEMBL450895
 

Indication

 

chronic mucocutaneous candidiasis, cutaneous candidiasis, mycoses, oral candidiasis, vulvovaginal candidiasis
 

Drug Class

 

Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)

Image (chem structure or protein)

Nystatin structure rendering